Authors: Taras, TL Wurz, GT DeGregorio, MW

Citation: Tl. Taras et al., In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer, J STEROID B, 77(4-5), 2001, pp. 271-279

Authors: Taras, TL Wurz, GT Linares, GR DeGregorio, MW

Citation: Tl. Taras et al., Clinical pharmacokinetics of toremifene, CLIN PHARMA, 39(5), 2000, pp. 327-334

Authors: Hellmann-Blumberg, U Taras, TL Wurz, GT DeGregorio, MW

Citation: U. Hellmann-blumberg et al., Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene, BREAST CANC, 60(1), 2000, pp. 63-70

Authors: DeGregorio, MW Wurz, GT Taras, TL Erkkola, RU Halonen, KH Huupponen, RK

Citation: Mw. Degregorio et al., Pharmacokinetics of (deaminohydroxy)toremifene in humans: a new, selectiveestrogen-receptor modulator, EUR J CL PH, 56(6-7), 2000, pp. 469-475

Authors: Taras, TL Wurz, GT Hellmann-Blumberg, U DeGregorio, MW

Citation: Tl. Taras et al., Quantitative analysis of Z-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol in human plasma using high-performance liquid chromatography, J CHROMAT B, 724(1), 1999, pp. 163-171